更正：PCC0208025（BMS202），一种PD-L1小分子抑制剂，在携带B16-F10黑色素瘤的小鼠中产生抗肿瘤作用。
Correction: PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice.
出版信息
PLoS One. 2021 Apr 28;16(4):e0251020. doi: 10.1371/journal.pone.0251020. eCollection 2021.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0228339.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0228339。]
相似文献
1
Correction: PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice.更正：PCC0208025（BMS202），一种PD-L1小分子抑制剂，在携带B16-F10黑色素瘤的小鼠中产生抗肿瘤作用。
PLoS One. 2021 Apr 28;16(4):e0251020. doi: 10.1371/journal.pone.0251020. eCollection 2021.
2
PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice.PCC0208025（BMS202）是一种 PD-L1 的小分子抑制剂，在 B16-F10 黑色素瘤荷瘤小鼠中产生抗肿瘤作用。
PLoS One. 2020 Mar 26;15(3):e0228339. doi: 10.1371/journal.pone.0228339. eCollection 2020.
3
Combined SEP and anti-PD-L1 antibody produces a synergistic antitumor effect in B16-F10 melanoma-bearing mice.联合 SEP 和抗 PD-L1 抗体可在 B16-F10 黑色素瘤荷瘤小鼠中产生协同抗肿瘤作用。
Sci Rep. 2018 Jan 9;8(1):217. doi: 10.1038/s41598-017-18641-y.
4
Novel Treatment of Melanoma: Combined Parasite-Derived Peptide GK-1 and Anti-Programmed Death Ligand 1 Therapy.黑色素瘤的新型治疗方法：寄生虫衍生肽GK-1与抗程序性死亡配体1疗法联合应用
Cancer Biother Radiopharm. 2017 Mar;32(2):49-56. doi: 10.1089/cbr.2016.2123.
5
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells.放化疗可增加某些黑色素瘤和胶质母细胞瘤细胞中PD-L1的表达。
Front Immunol. 2016 Dec 22;7:610. doi: 10.3389/fimmu.2016.00610. eCollection 2016.
6
Evaluation of [C]NMS-E973 as a PET tracer for visualisation of HSP90.评估 [C]NMS-E973 作为一种 PET 示踪剂，用于 HSP90 的可视化。
Theranostics. 2019 Jan 1;9(2):554-572. doi: 10.7150/thno.27213. eCollection 2019.
7
Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells.增强体内针对黑色素瘤细胞疫苗的细胞毒性T淋巴细胞反应：使用经γ干扰素预刺激和β干扰素处理的B7-1+B16-F10黑色素瘤细胞获得协同增强效果。
Immunol Cell Biol. 2003 Dec;81(6):459-71. doi: 10.1046/j.0818-9641.2003.01189.x.
8
Evaluation of [C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma.评估 [C]KB631 作为一种 PET 示踪剂，用于体内可视化 B16.F10 黑色素瘤中的 HDAC6。
Nucl Med Biol. 2019 Jul-Aug;74-75:1-11. doi: 10.1016/j.nucmedbio.2019.05.004. Epub 2019 May 29.
9
IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.通过体内电穿孔递送白细胞介素-12质粒成功治疗已形成的皮下B16.F10黑色素瘤。
Mol Ther. 2002 Jun;5(6):668-75. doi: 10.1006/mthe.2002.0601.
10
Effects of DL-alpha-difluoromethylornithine on the growth and metastasis of B16 melanoma in vivo.
Int J Cancer. 1987 Feb 15;39(2):244-7. doi: 10.1002/ijc.2910390220.
本文引用的文献
1
PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice.PCC0208025（BMS202）是一种 PD-L1 的小分子抑制剂，在 B16-F10 黑色素瘤荷瘤小鼠中产生抗肿瘤作用。
PLoS One. 2020 Mar 26;15(3):e0228339. doi: 10.1371/journal.pone.0228339. eCollection 2020.
Zotero 插件